The global DHA Algae Oil in Infant Formula Market Comprehensive Study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments -By Type (30 to 40% Content, 40 to 50% Content), By Application (0 to 12 Months, 1 to 2 Years, Others)
The DHA Algae Oil in Infant Formula market in 2024 is expanding rapidly, driven by the increasing demand for high-quality and nutritionally complete infant nutrition products. DHA algae oil, rich in docosahexaenoic acid (DHA), is added to infant formulas to support brain and eye development in infants. The market is supported by the growing awareness of the importance of DHA in early childhood development. Advances in algae cultivation and oil extraction technologies are enhancing the quality, purity, and bioavailability of DHA algae oil for use in infant formulas. The market is also benefiting from the trend towards clean-label and scientifically backed ingredients, appealing to parents seeking the best nutritional options for their infants.
The market report analyses the leading companies in the industry including Cabio Biotechnology (Wuhan) Co., Ltd., Cellana, FEMICO, Fuxing (Group) Co., Ltd., Huison Biotech Co., Ltd., JC Biotech Co., Ltd., Keyuan Biopharma, Kingdomway Group, Lonza Group Ltd, Roquette Frères, Royal DSM N.V., Runke Bioengineering Co., Ltd., Yidie Bioengineering Co., Ltd., Yuexiang, and Others.
A prominent trend in the DHA algae oil in infant formula market is the growing emphasis on brain development and nutrition in early childhood. Parents and caregivers are increasingly aware of the importance of DHA (docosahexaenoic acid) for cognitive development, visual acuity, and overall health in infants. As a result, there is a rising demand for infant formulas fortified with DHA algae oil to provide essential omega-3 fatty acids for optimal brain and eye development during the critical stages of infancy.
A key driver influencing the DHA algae oil in infant formula market is parental focus on holistic health and nutritional benefits for their babies. Parents are actively seeking infant formula options that mimic the nutritional composition of breast milk, including important nutrients like DHA, which plays a vital role in brain and vision development. This driver is pushing formula manufacturers to enhance their products with DHA algae oil to meet the nutritional needs and expectations of health-conscious parents seeking the best start for their infants.
An exciting opportunity in the DHA algae oil in infant formula market lies in innovation in premium and specialty infant formulas. There is potential to develop specialized infant formulas that offer higher levels of DHA from algae oil, catering to parents who prioritize brain development and cognitive health in their infants. Additionally, there is an opportunity to create organic, non-GMO, allergen-free, and other specialty formula options fortified with DHA algae oil, targeting niche markets and addressing specific parental preferences and dietary considerations. This innovation in premium and specialty infant formulas allows companies to differentiate their products, provide added value to consumers, and tap into the growing market for high-quality, nutritionally enriched infant nutrition solutions.
The 40 to 50% Content DHA Algae Oil segment emerges as the largest category in the DHA Algae Oil in Infant Formula Market, showcasing rapid growth driven by its superior nutritional profile and increasing demand for high-quality infant nutrition. DHA (docosahexaenoic acid) is a critical omega-3 fatty acid essential for infant brain development, cognitive function, and visual acuity. Infant formulas fortified with DHA algae oil containing 40 to 50% content ensure a potent and concentrated source of this vital nutrient, making them highly sought-after by parents and caregivers seeking optimal nutrition for their infants. The efficacy and bioavailability of DHA in this content range are crucial for supporting early childhood development, making it a cornerstone ingredient in infant formula formulations. Additionally, the growing awareness among parents about the benefits of DHA supplementation in infant diets further drives the adoption of DHA-fortified formulas. Further, regulatory initiatives emphasizing the importance of DHA in infant nutrition and advancements in manufacturing techniques contribute to the rapid growth of this segment. As parents prioritize the health and development of their infants, the 40 to 50% Content DHA Algae Oil segment remains at the forefront, driving market growth and innovation in the DHA Algae Oil in Infant Formula Market.
The 0 to 12 Months Application segment within the DHA Algae Oil in Infant Formula Market emerges as the fastest-growing category projected to experience substantial growth by 2032. This surge is propelled by several critical factors. Firstly, the first year of life is crucial for infant growth, development, and brain formation, making it a period where nutritional requirements are paramount. DHA (docosahexaenoic acid), an essential omega-3 fatty acid, plays a vital role in supporting brain development, cognitive function, and visual acuity during infancy. Infant formulas fortified with DHA algae oil tailored for the 0 to 12 months age group ensure a potent and concentrated source of this essential nutrient, meeting the specific nutritional needs of infants during this critical phase. Additionally, parental awareness and education regarding the importance of DHA supplementation in infant diets contribute to the rising demand for DHA-fortified formulas in this age category. Further, regulatory support and recommendations from healthcare professionals emphasizing the benefits of DHA further drive the growth of this segment. As parents prioritize the health and well-being of their infants, the 0 to 12 Months Application of DHA Algae Oil in infant formula emerges as a pivotal segment driving market growth and innovation in the DHA Algae Oil in Infant Formula Market.
By Type
30 to 40% Content
40 to 50% Content
By Application
0 to 12 Months
1 to 2 Years
Others
Countries Analyzed
North America (US, Canada, Mexico)
Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Australia, South East Asia, Rest of Asia)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)
Cabio Biotechnology (Wuhan) Co., Ltd.
Cellana
FEMICO
Fuxing (Group) Co., Ltd.
Huison Biotech Co., Ltd.
JC Biotech Co., Ltd.
Keyuan Biopharma
Kingdomway Group
Lonza Group Ltd
Roquette Frères
Royal DSM N.V.
Runke Bioengineering Co., Ltd.
Yidie Bioengineering Co., Ltd.
Yuexiang
*- List Not Exhaustive
Chapter 1. TABLE OF CONTENTS
Chapter 2. Introduction to DHA Algae Oil in Infant Formula Market
2.1. Market Overview
2.2. Key Statistics and Report Highlights
2.3. Scope of the Comprehensive Study
2.3.1. Market Definition
2.3.2 Countries and Regions Covered
2.3.3 Research Objective
2.3.4 Units, Currency, and Conversions
2.3.5 Industry Value Chain
2.4. Key Market Segments
2.5. Key Companies
2.6. Study Period
Chapter 3. Strategic Analysis Review
3.1. DHA Algae Oil in Infant Formula Pricing Analysis and Forecast
3.2. Porter’s Five Forces
3.3. Market Ecosystem
3.4. SWOT Analysis
3.5. Regulatory Scenario
3.3. Effects of Inflation, Russia-Ukraine War, moderating economic growth, and other macroeconomic factors
Chapter 4. Competitive Landscape
4.1. Market Share Analysis
4.1.1. Global DHA Algae Oil in Infant Formula Market Share by Company, 2023
4.1.2. Product Offerings of Leading DHA Algae Oil in Infant Formula Companies
4.2. Market Entropy
4.2.1. New Product Launches in the Industry
4.2.2. Mergers, Acquisitions, Joint ventures, and Partnerships
4.3. Key Strategies and Best Practices
Chapter 5. Global Market Projections: Best, Reference, and Low Case Scenarios
5.1. Growth Analysis- Case Scenario Definitions
5.2. Low Growth Case Scenario Forecasts
5.3. Reference Growth Case Scenario Forecasts
5.4. High Growth Case Scenario Forecasts
Chapter 6. Market Dynamics
6.1. DHA Algae Oil in Infant Formula Market Drivers
6.2. DHA Algae Oil in Infant Formula Market Challenges
6.6. DHA Algae Oil in Infant Formula Market Opportunities
6.4. DHA Algae Oil in Infant Formula Market Trends
Chapter 7. Global DHA Algae Oil in Infant Formula Market Outlook Trends
7.1. Global DHA Algae Oil in Infant Formula Revenue (USD Million) and CAGR (%) by Type (2021-2032)
7.2. Global DHA Algae Oil in Infant Formula Revenue (USD Million) and CAGR (%) by Application (2021-2032)
7.3. Global DHA Algae Oil in Infant Formula Revenue (USD Million) and CAGR (%) by Product (2021-2032)
By Type
30 to 40% Content
40 to 50% Content
By Application
0 to 12 Months
1 to 2 Years
Others
Chapter 8. Global DHA Algae Oil in Infant Formula Regional Analysis and Outlook
8.1. Global DHA Algae Oil in Infant Formula Revenue (USD Million) By Regions (2021- 2032)
8.2. North America DHA Algae Oil in Infant Formula Revenue (USD Million) by Country (2021-2032)
8.2.1. United States DHA Algae Oil in Infant Formula Regional Analysis and Outlook
8.2.2. Canada DHA Algae Oil in Infant Formula Regional Analysis and Outlook
8.2.3. Mexico DHA Algae Oil in Infant Formula Regional Analysis and Outlook
8.3. Europe DHA Algae Oil in Infant Formula Revenue (USD Million), by Country (2021-2032)
8.3.1. Germany DHA Algae Oil in Infant Formula Regional Analysis and Outlook
8.3.2. France DHA Algae Oil in Infant Formula Regional Analysis and Outlook
8.3.3. United Kingdom DHA Algae Oil in Infant Formula Regional Analysis and Outlook
8.3.4. Spain DHA Algae Oil in Infant Formula Regional Analysis and Outlook
8.3.5. Italy DHA Algae Oil in Infant Formula Regional Analysis and Outlook
8.3.6. Russia DHA Algae Oil in Infant Formula Regional Analysis and Outlook
8.3.7. Rest of Europe DHA Algae Oil in Infant Formula Regional Analysis and Outlook
8.4. Asia Pacific DHA Algae Oil in Infant Formula Revenue (USD Million) by Country (2021-2032)
8.4.1. China DHA Algae Oil in Infant Formula Regional Analysis and Outlook
8.4.2. Japan DHA Algae Oil in Infant Formula Regional Analysis and Outlook
8.4.3. India DHA Algae Oil in Infant Formula Regional Analysis and Outlook
8.4.4. South Korea DHA Algae Oil in Infant Formula Regional Analysis and Outlook
8.4.5. Australia DHA Algae Oil in Infant Formula Regional Analysis and Outlook
8.4.6. South East Asia DHA Algae Oil in Infant Formula Regional Analysis and Outlook
8.4.7. Rest of Asia Pacific DHA Algae Oil in Infant Formula Regional Analysis and Outlook
8.5. South America DHA Algae Oil in Infant Formula Revenue (USD Million), by Country (2021-2032)
8.5.1. Brazil DHA Algae Oil in Infant Formula Regional Analysis and Outlook
8.5.2. Argentina DHA Algae Oil in Infant Formula Regional Analysis and Outlook
8.5.3. Rest of South America DHA Algae Oil in Infant Formula Regional Analysis and Outlook
8.6. Middle East and Africa DHA Algae Oil in Infant Formula Revenue (USD Million) by Country (2021-2032)
8.6.1. Middle East DHA Algae Oil in Infant Formula Regional Analysis and Outlook
8.6.2. Africa DHA Algae Oil in Infant Formula Regional Analysis and Outlook
Chapter 9. North America DHA Algae Oil in Infant Formula Analysis and Outlook
9.1. North America DHA Algae Oil in Infant Formula Revenue (USD Million) by Segments (2021-2032)
9.1.1. North America DHA Algae Oil in Infant Formula Revenue (USD Million) by Type (2021-2032)
9.1.2. North America DHA Algae Oil in Infant Formula Revenue (USD Million) by Application (2021-2032)
9.1.3. North America DHA Algae Oil in Infant Formula Revenue (USD Million) by Product (2021-2032)
By Type
30 to 40% Content
40 to 50% Content
By Application
0 to 12 Months
1 to 2 Years
Others
Chapter 10. Europe DHA Algae Oil in Infant Formula Analysis and Outlook
10.1. Europe DHA Algae Oil in Infant Formula Revenue (USD Million), by Segments (USD Million) (2021-2032)
10.1.1. Europe DHA Algae Oil in Infant Formula Revenue (USD Million) by Type (2021-2032)
10.1.2. Europe DHA Algae Oil in Infant Formula Revenue (USD Million) by Application (2021-2032)
10.1.3. Europe DHA Algae Oil in Infant Formula Revenue (USD Million) by Product (2021-2032)
By Type
30 to 40% Content
40 to 50% Content
By Application
0 to 12 Months
1 to 2 Years
Others
Chapter 11. Asia Pacific DHA Algae Oil in Infant Formula Analysis and Outlook
11.1. Asia Pacific DHA Algae Oil in Infant Formula Revenue (USD Million), and Revenue (USD Million) by Segments (2021-2032)
11.1.1. Asia Pacific DHA Algae Oil in Infant Formula Revenue (USD Million) by Type (2021-2032)
11.1.2. Asia Pacific DHA Algae Oil in Infant Formula Revenue (USD Million) by Application (2021-2032)
11.1.3. Asia Pacific DHA Algae Oil in Infant Formula Revenue (USD Million) by Product (2021-2032)
By Type
30 to 40% Content
40 to 50% Content
By Application
0 to 12 Months
1 to 2 Years
Others
Chapter 12. South America DHA Algae Oil in Infant Formula Analysis and Outlook
12.1. South America DHA Algae Oil in Infant Formula Revenue (USD Million), by Segments (2021-2032)
12.1.1. South America DHA Algae Oil in Infant Formula Revenue (USD Million) by Type (2021-2032)
12.1.2. South America DHA Algae Oil in Infant Formula Revenue (USD Million) by Application (2021-2032)
12.1.3. South America DHA Algae Oil in Infant Formula Revenue (USD Million) by Product (2021-2032)
By Type
30 to 40% Content
40 to 50% Content
By Application
0 to 12 Months
1 to 2 Years
Others
Chapter 13. Middle East and Africa DHA Algae Oil in Infant Formula Analysis and Outlook
13.1. Middle East and Africa DHA Algae Oil in Infant Formula Revenue (USD Million), by Segments (2021-2032)
13.1.1. Middle East and Africa DHA Algae Oil in Infant Formula Revenue (USD Million) by Type (2021-2032)
13.1.2. Middle East and Africa DHA Algae Oil in Infant Formula Revenue (USD Million) by Application (2021-2032)
13.1.3. Middle East and Africa DHA Algae Oil in Infant Formula Revenue (USD Million) by Product (2021-2032)
By Type
30 to 40% Content
40 to 50% Content
By Application
0 to 12 Months
1 to 2 Years
Others
Chapter 14. DHA Algae Oil in Infant Formula Company Profiles
14.1 Business Overview
14.2 Product Profiles
14.3 SWOT Profiles
14.5 Recent Developments
14.6 Financial Profile
List of Companies
Cabio Biotechnology (Wuhan) Co., Ltd.
Cellana
FEMICO
Fuxing (Group) Co., Ltd.
Huison Biotech Co., Ltd.
JC Biotech Co., Ltd.
Keyuan Biopharma
Kingdomway Group
Lonza Group Ltd
Roquette Frères
Royal DSM N.V.
Runke Bioengineering Co., Ltd.
Yidie Bioengineering Co., Ltd.
Yuexiang
15. Methodology and Data Sources
15.1 Customization Offerings
15.2 Subscription Services
15.3 Related Reports
15.4 Publisher Expertise
LIST OF TABLES
Table 1 Market Segmentation Analysis
Table 2 Global DHA Algae Oil in Infant Formula Market Share of Leading Companies, 2023
Table 3 Product Offerings of Leading Companies
Table 4 Low Growth Scenario Forecasts
Table 5 Reference Case Growth Scenario
Table 6 High Growth Case Scenario
Table 7 Global DHA Algae Oil in Infant Formula Revenue (USD Million) And CAGR (%) By Type (2021-2032)
Table 8 Global DHA Algae Oil in Infant Formula Revenue (USD Million) And CAGR (%) By Application (2021-2032)
Table 9 Global DHA Algae Oil in Infant Formula Revenue (USD Million) And CAGR (%) By Product (2021-2032)
Table 10 Global DHA Algae Oil in Infant Formula Market Revenue (USD Million) By Regions (2021-2032)
Table 11 Global DHA Algae Oil in Infant Formula Market Share (%) By Regions (2021-2032)
Table 12 North America DHA Algae Oil in Infant Formula Revenue (USD Million) By Country (2021-2032)
Table 13 Europe DHA Algae Oil in Infant Formula Revenue (USD Million) By Country (2021-2032)
Table 14 Asia Pacific DHA Algae Oil in Infant Formula Revenue (USD Million) By Country (2021-2032)
Table 15 South America DHA Algae Oil in Infant Formula Revenue (USD Million) By Country (2021-2032)
Table 16 Middle East and Africa DHA Algae Oil in Infant Formula Revenue (USD Million) By Region (2021-2032)
Table 17 North America DHA Algae Oil in Infant Formula Revenue (USD Million) By Type (2021-2032)
Table 18 North America DHA Algae Oil in Infant Formula Revenue (USD Million) By Application (2021-2032)
Table 19 North America DHA Algae Oil in Infant Formula Revenue (USD Million) By Product (2021-2032)
Table 20 Europe DHA Algae Oil in Infant Formula Revenue (USD Million) By Type (2021-2032)
Table 21 Europe DHA Algae Oil in Infant Formula Revenue (USD Million) By Application (2021-2032)
Table 22 Europe DHA Algae Oil in Infant Formula Revenue (USD Million) By Product (2021-2032)
Table 23 Asia Pacific DHA Algae Oil in Infant Formula Revenue (USD Million) By Type (2021-2032)
Table 24 Asia Pacific DHA Algae Oil in Infant Formula Revenue (USD Million) By Application (2021-2032)
Table 25 Asia Pacific DHA Algae Oil in Infant Formula Revenue (USD Million) By Product (2021-2032)
Table 26 South America DHA Algae Oil in Infant Formula Revenue (USD Million) By Type (2021-2032)
Table 27 South America DHA Algae Oil in Infant Formula Revenue (USD Million) By Application (2021-2032)
Table 28 South America DHA Algae Oil in Infant Formula Revenue (USD Million) By Product (2021-2032)
Table 29 Middle East and Africa DHA Algae Oil in Infant Formula Revenue (USD Million) By Type (2021-2032)
Table 30 Middle East and Africa DHA Algae Oil in Infant Formula Revenue (USD Million) By Application (2021-2032)
Table 31 Middle East and Africa DHA Algae Oil in Infant Formula Revenue (USD Million) By Product (2021-2032)
LIST OF FIGURES
Figure 1. Market Scope
Figure 2. Pricing Forecasts Per Unit, 2023- 2032
Figure 3. Porter’s Five Forces
Figure 4. Global DHA Algae Oil in Infant Formula Market Revenue (USD Million) By Regions (2021-2032)
Figure 5. Global DHA Algae Oil in Infant Formula Market Share (%) By Regions (2023)
Figure 6. North America DHA Algae Oil in Infant Formula Revenue (USD Million) By Country (2021-2032)
Figure 7. United States DHA Algae Oil in Infant Formula Revenue (USD Million) By Country (2021-2032)
Figure 8. Canada DHA Algae Oil in Infant Formula Revenue (USD Million) By Country (2021-2032)
Figure 9. Mexico DHA Algae Oil in Infant Formula Revenue (USD Million) By Country (2021-2032)
Figure 10. Europe DHA Algae Oil in Infant Formula Revenue (USD Million) By Country (2021-2032)
Figure 11. Germany DHA Algae Oil in Infant Formula Revenue (USD Million) By Country (2021-2032)
Figure 12. France DHA Algae Oil in Infant Formula Revenue (USD Million) By Country (2021-2032)
Figure 13. United Kingdom DHA Algae Oil in Infant Formula Revenue (USD Million) By Country (2021-2032)
Figure 14. Spain DHA Algae Oil in Infant Formula Revenue (USD Million) By Country (2021-2032)
Figure 15. Italy DHA Algae Oil in Infant Formula Revenue (USD Million) By Country (2021-2032)
Figure 16. Russia DHA Algae Oil in Infant Formula Revenue (USD Million) By Country (2021-2032)
Figure 17. Rest of Europe DHA Algae Oil in Infant Formula Revenue (USD Million) By Country (2021-2032)
Figure 11. Asia Pacific DHA Algae Oil in Infant Formula Revenue (USD Million) By Country (2021-2032)
Figure 12. China DHA Algae Oil in Infant Formula Revenue (USD Million) By Country (2021-2032)
Figure 13. Japan DHA Algae Oil in Infant Formula Revenue (USD Million) By Country (2021-2032)
Figure 14. India DHA Algae Oil in Infant Formula Revenue (USD Million) By Country (2021-2032)
Figure 15. South Korea DHA Algae Oil in Infant Formula Revenue (USD Million) By Country (2021-2032)
Figure 16. Australia DHA Algae Oil in Infant Formula Revenue (USD Million) By Country (2021-2032)
Figure 17. South East Asia DHA Algae Oil in Infant Formula Revenue (USD Million) By Country (2021-2032)
Figure 18. South America DHA Algae Oil in Infant Formula Revenue (USD Million) By Country (2021-2032)
Figure 19. Brazil DHA Algae Oil in Infant Formula Revenue (USD Million) By Country (2021-2032)
Figure 20. Argentina DHA Algae Oil in Infant Formula Revenue (USD Million) By Country (2021-2032)
Figure 21. Rest of Asia Pacific DHA Algae Oil in Infant Formula Revenue (USD Million) By Country (2021-2032)
Figure 22. Middle East and Africa DHA Algae Oil in Infant Formula Revenue (USD Million) By Region (2021-2032)
Figure 23. Saudi Arabia DHA Algae Oil in Infant Formula Revenue (USD Million) By Region (2021-2032)
Figure 24. The UAE DHA Algae Oil in Infant Formula Revenue (USD Million) By Region (2021-2032)
Figure 25. Rest of Middle East DHA Algae Oil in Infant Formula Revenue (USD Million) By Region (2021-2032)
Figure 26. South Africa DHA Algae Oil in Infant Formula Revenue (USD Million) By Region (2021-2032)
Figure 27. Africa DHA Algae Oil in Infant Formula Revenue (USD Million) By Region (2021-2032)
Figure 28. North America DHA Algae Oil in Infant Formula Revenue (USD Million) By Type (2021-2032)
Figure 29. North America DHA Algae Oil in Infant Formula Revenue (USD Million) By Application (2021-2032)
Figure 30. North America DHA Algae Oil in Infant Formula Revenue (USD Million) By Product (2021-2032)
Figure 31. Europe DHA Algae Oil in Infant Formula Revenue (USD Million) By Type (2021-2032)
Figure 32. Europe DHA Algae Oil in Infant Formula Revenue (USD Million) By Application (2021-2032)
Figure 33. Europe DHA Algae Oil in Infant Formula Revenue (USD Million) By Product (2021-2032)
Figure 34. Asia Pacific DHA Algae Oil in Infant Formula Revenue (USD Million) By Type (2021-2032)
Figure 35. Asia Pacific DHA Algae Oil in Infant Formula Revenue (USD Million) By Application (2021-2032)
Figure 36. Asia Pacific DHA Algae Oil in Infant Formula Revenue (USD Million) By Product (2021-2032)
Figure 37. South America DHA Algae Oil in Infant Formula Revenue (USD Million) By Type (2021-2032)
Figure 38. South America DHA Algae Oil in Infant Formula Revenue (USD Million) By Application (2021-2032)
Figure 39. South America DHA Algae Oil in Infant Formula Revenue (USD Million) By Product (2021-2032)
Figure 40. Middle East and Africa DHA Algae Oil in Infant Formula Revenue (USD Million) By Type (2021-2032)
Figure 41. Middle East and Africa DHA Algae Oil in Infant Formula Revenue (USD Million) By Application (2021-2032)
Figure 42. Middle East and Africa DHA Algae Oil in Infant Formula Revenue (USD Million) By Product (2021-2032)
By Type
30 to 40% Content
40 to 50% Content
By Application
0 to 12 Months
1 to 2 Years
Others
Countries Analyzed
North America (US, Canada, Mexico)
Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Australia, South East Asia, Rest of Asia)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)
Global DHA Algae Oil in Infant Formula Market Size is valued at $102.1 Million in 2024 and is forecast to register a growth rate (CAGR) of 8.8% to reach $200.5 Million by 2032.
Emerging Markets across Asia Pacific, Europe, and Americas present robust growth prospects.
Cabio Biotechnology (Wuhan) Co., Ltd., Cellana, FEMICO, Fuxing (Group) Co., Ltd., Huison Biotech Co., Ltd., JC Biotech Co., Ltd., Keyuan Biopharma, Kingdomway Group, Lonza Group Ltd, Roquette Frères, Royal DSM N.V., Runke Bioengineering Co., Ltd., Yidie Bioengineering Co., Ltd., Yuexiang
Base Year- 2023; Estimated Year- 2024; Historic Period- 2018-2023; Forecast period- 2024 to 2032; Currency: Revenue (USD); Volume